학술논문
Cost-effectiveness of olaparib as a maintenance treatment for women with newly diagnosed advanced ovarian cancer and BRCA1/2 mutations in the United States
Document Type
Article
Author
Source
In Gynecologic Oncology November 2020 159(2):491-497
Subject
Language
ISSN
0090-8258